Related references
Note: Only part of the references are listed.Use of biologics for psoriasis in Central and Eastern European countries
F. Rencz et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective
Fabien B. Vincent et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Experience with biologics for psoriasis in daily practice: switching is worth a try
L. L. A. Lecluse et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials
J. Schmitt et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Tuberculosis in the age of biologic therapy
Claudia Hernandez et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Biologic therapies in psoriasis: A new therapeutic approach
Paolo Gisondi et al.
AUTOIMMUNITY REVIEWS (2007)
The immunology of psoriasis and biologic immunotherapy
SL Mehlis et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
Share Paper
